These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 33850306)
1. Impact of in-hospital blood pressure variability on clinical outcomes in patients with symptomatic peripheral arterial disease. Suzuki M; Saito Y; Kitahara H; Saito K; Takahara M; Himi T; Kobayashi Y Hypertens Res; 2021 Aug; 44(8):1002-1008. PubMed ID: 33850306 [TBL] [Abstract][Full Text] [Related]
2. In-Hospital Blood Pressure Variability: A Novel Prognostic Marker of Renal Function Decline and Cardiovascular Events in Patients with Coronary Artery Disease. Saito K; Saito Y; Kitahara H; Nakayama T; Fujimoto Y; Kobayashi Y Kidney Blood Press Res; 2020; 45(5):748-757. PubMed ID: 33027787 [TBL] [Abstract][Full Text] [Related]
3. Visit-to-visit blood pressure variability is a strong predictor of cardiovascular events in hemodialysis: insights from FOSIDIAL. Rossignol P; Cridlig J; Lehert P; Kessler M; Zannad F Hypertension; 2012 Aug; 60(2):339-46. PubMed ID: 22777936 [TBL] [Abstract][Full Text] [Related]
4. Predictive value of visit-to-visit blood pressure variability for cardiovascular events in patients with coronary artery disease with and without diabetes mellitus. Wong YK; Chan YH; Hai JSH; Lau KK; Tse HF Cardiovasc Diabetol; 2021 Apr; 20(1):88. PubMed ID: 33894788 [TBL] [Abstract][Full Text] [Related]
5. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395 [TBL] [Abstract][Full Text] [Related]
6. Increased blood pressure variability during the subacute phase in patients with ischemic stroke presenting with a low ankle-brachial index. Naito H; Hosomi N; Kuzume D; Nezu T; Aoki S; Morimoto Y; Kinboshi M; Yoshida T; Shiga Y; Kinoshita N; Ueno H; Noma K; Maruyama H Geriatr Gerontol Int; 2020 May; 20(5):448-454. PubMed ID: 32134185 [TBL] [Abstract][Full Text] [Related]
7. Dapagliflozin and Cardiac, Kidney, and Limb Outcomes in Patients With and Without Peripheral Artery Disease in DECLARE-TIMI 58. Bonaca MP; Wiviott SD; Zelniker TA; Mosenzon O; Bhatt DL; Leiter LA; McGuire DK; Goodrich EL; De Mendonca Furtado RH; Wilding JPH; Cahn A; Gause-Nilsson IAM; Johanson P; Fredriksson M; Johansson PA; Langkilde AM; Raz I; Sabatine MS Circulation; 2020 Aug; 142(8):734-747. PubMed ID: 32795086 [TBL] [Abstract][Full Text] [Related]
8. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure. Skoglund PH; Arpegård J; Ostergren J; Svensson P Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529 [TBL] [Abstract][Full Text] [Related]
9. In-hospital day-by-day systolic blood pressure variability during rehabilitation: a marker of adverse outcome in secondary prevention after myocardial revascularization. Lazzeroni D; Camaiora U; Castiglioni P; Bini M; Garibaldi S; Geroldi S; Moderato L; Brambilla L; Brambilla V; Parati G; Coruzzi P J Hypertens; 2020 Sep; 38(9):1729-1736. PubMed ID: 32516294 [TBL] [Abstract][Full Text] [Related]
10. Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD Trial. Bauersachs RM; Szarek M; Brodmann M; Gudz I; Debus ES; Nehler MR; Anand SS; Patel MR; Hess CN; Capell WH; Rogers K; Muehlhofer E; Haskell LP; Berkowitz SD; Hiatt WR; Bonaca MP; J Am Coll Cardiol; 2021 Jul; 78(4):317-326. PubMed ID: 34010631 [TBL] [Abstract][Full Text] [Related]
11. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease. Bonaca MP; Bhatt DL; Storey RF; Steg PG; Cohen M; Kuder J; Goodrich E; Nicolau JC; Parkhomenko A; López-Sendón J; Dellborg M; Dalby A; Špinar J; Aylward P; Corbalán R; Abola MTB; Jensen EC; Held P; Braunwald E; Sabatine MS J Am Coll Cardiol; 2016 Jun; 67(23):2719-2728. PubMed ID: 27046162 [TBL] [Abstract][Full Text] [Related]
12. Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial. Gutierrez JA; Mulder H; Jones WS; Rockhold FW; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Held P; Katona BG; Mahaffey KW; Norgren L; Hiatt WR; Patel MR JAMA Netw Open; 2018 Nov; 1(7):e185239. PubMed ID: 30646395 [TBL] [Abstract][Full Text] [Related]
14. Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD). Capell WH; Bonaca MP; Nehler MR; Chen E; Kittelson JM; Anand SS; Berkowitz SD; Debus ES; Fanelli F; Haskell L; Patel MR; Bauersachs R; Hiatt WR Am Heart J; 2018 May; 199():83-91. PubMed ID: 29754671 [TBL] [Abstract][Full Text] [Related]
15. Association of Hypertension and Arterial Blood Pressure on Limb and Cardiovascular Outcomes in Symptomatic Peripheral Artery Disease: The EUCLID Trial. Fudim M; Hopley CW; Huang Z; Kavanagh S; Rockhold FW; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Katona BG; Mahaffey KW; Norgren L; Ostrom C; Patel MR; Jones WS; Hiatt WR Circ Cardiovasc Qual Outcomes; 2020 Sep; 13(9):e006512. PubMed ID: 32862697 [TBL] [Abstract][Full Text] [Related]
16. Major Adverse Limb Events and 1-Year Outcomes After Peripheral Artery Revascularization. Hess CN; Rogers RK; Wang TY; Fu R; Gundrum J; Allen LaPointe NM; Hiatt WR J Am Coll Cardiol; 2018 Aug; 72(9):999-1011. PubMed ID: 30139446 [TBL] [Abstract][Full Text] [Related]
17. Mid-Term Blood Pressure Variability Is Associated With Clinical Outcome After Ischemic Stroke. Wang Y; Wang J; Meng P; Liu N; Ji N; Zhang G; Xu B; Zhou X; Sun Y; Xu Y; Hui R; He M Am J Hypertens; 2017 Oct; 30(10):968-977. PubMed ID: 28633329 [TBL] [Abstract][Full Text] [Related]